First Trust NYSE Arca Biotechnology Index Fund
116 hedge funds and large institutions have $447M invested in First Trust NYSE Arca Biotechnology Index Fund in 2017 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 41 increasing their positions, 24 reducing their positions, and 19 closing their positions.
71% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 24
21% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 19
12% more capital invested
Capital invested by funds: $398M → $447M (+$48.5M)
4% more funds holding
Funds holding: 112 → 116 (+4)
0.25% less ownership
Funds ownership: 39.02% → 38.77% (-0.25%)
5% less call options, than puts
Call options by funds: $2.24M | Put options by funds: $2.37M
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$6.6M |
| 2 |
Morgan Stanley
New York
|
+$5.56M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$4.09M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.81M |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NA
Navellier & Associates
Reno,
Nevada
|
-$18.5M |
| 2 |
Jane Street
New York
|
-$3.62M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$2.77M |
| 4 |
MCWS
McKinley Carter Wealth Services
Wheeling,
West Virginia
|
-$2.61M |
| 5 |
HH
Hilltop Holdings
Dallas,
Texas
|
-$1.24M |
FBT Hedge Fund Activity: Q3 2017 in Review
116 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q3 2017, worth a combined $447M — up 12% from $398M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new FBT positions and 19 closed out — a net gain of 4 holders — while 41 added to existing stakes and 24 trimmed.
The largest buyer was Bank of America, adding an estimated $6.6M. The largest seller was Navellier & Associates, cutting an estimated $18.5M.
- 116 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q3 2017, up from 112 in Q2 2017.
- Funds reported $447M of First Trust NYSE Arca Biotechnology Index Fund stock for Q3 2017, up 12% quarter-over-quarter.
- 23 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q3 2017 and 19 closed out, a net change of +4 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q3 2017 was Bank of America, an estimated $6.6M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q3 2017 was Navellier & Associates, an estimated $18.5M sold.
Based on aggregated 13F filings for Q3 2017.